Evidence map›Paper›PMID 38260573›Full record

ArticlebioRxiv : the preprint server for biology2024

Mutation of a highly conserved isoleucine residue in loop 2 of several

Catherine M Kerr, Jessica J Pfannenstiel, Yousef M Alhammad, Joseph J O'Connor, Roshan Ghimire, Rakshya Shrestha, Reem Khattabi, Pradtahna Saenjamsai, Srivatsan Parthasarathy, Peter R McDonald and 6 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Catherine M KerrDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.ORCID 0000-0001-7067-3778
Jessica J PfannenstielDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.ORCID 0009-0003-0783-3208
Yousef M AlhammadDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.ORCID 0000-0001-8435-9042
Joseph J O'ConnorDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.
Roshan GhimireDepartment of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma 74078, USA.ORCID 0000-0002-1397-3966
Rakshya ShresthaDepartment of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma 74078, USA.ORCID 0000-0002-1109-7966
Reem KhattabiDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.
Pradtahna SaenjamsaiDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.
Srivatsan ParthasarathyDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.
Peter R McDonaldHigh Throughput Screening Laboratory, University of Kansas, Lawrence, Kansas 66047, USA.ORCID 0000-0002-1880-7414
Philip GaoProtein Production Group, University of Kansas, Lawrence, Kansas 66047, USA.
David K JohnsonMolecular Graphics and Modeling Laboratory and the Computational Chemical Biology Core, University of Kansas, Lawrence, Kansas 66047, USA.
Sunil MoreHigh Throughput Screening Laboratory, University of Kansas, Lawrence, Kansas 66047, USA.ORCID 0000-0001-5007-8795
Anuradha RoyHigh Throughput Screening Laboratory, University of Kansas, Lawrence, Kansas 66047, USA.ORCID 0000-0002-1057-1443
Rudragouda ChannappanavarDepartment of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma 74078, USA.ORCID 0000-0002-7608-1922
Anthony R FehrDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.ORCID 0000-0003-1560-1573
University of Kansas · USOklahoma State University · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
Synthetic Chemical Biology CoreP20GM113117 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OROZCO, ROBIN C. · 2016 to 2025
$23.9M
ZFC3H1 Regulation of Host Defense and Influenza A Virus PathogenesisP20GM103648 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI CHANNAPPANAVAR, RUDRAGOUDA · 2013 to 2022
$22.3M
Graduate Training at the Biology-Chemistry InterfaceT32GM132061 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI Brian Douglas Ackley · 2020 to 2026
$2.9M
Determining mechanisms of innate immune modulation by ADP-ribosylationR35GM138029 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI Anthony R Fehr · 2020 to 2026
$2.7M
Investigating How ADP-ribosylation Impacts Innate Immunity During Coronavirus InfectionK22AI134993 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI FEHR, ANTHONY R · 2019 to 2020
$270k
NIAID NIH HHS K22 AI134993NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20 GM103648NIGMS NIH HHS P20 GM113117NIGMS NIH HHS R35 GM138029NIGMS NIH HHS T32 GM132061
6 · The paper itself

Abstract

All coronaviruses (CoVs) encode for a conserved macrodomain (Mac1) located in nonstructural protein 3 (nsp3). Mac1 is an ADP-ribosylhydrolase that binds and hydrolyzes mono-ADP-ribose from target proteins. Previous work has shown that Mac1 is important for virus replication and pathogenesis. Within Mac1, there are several regions that are highly conserved across CoVs, including the GIF (glycine-isoleucine-phenylalanine) motif. To determine how the biochemical activities of these residues impact CoV replication, the isoleucine and the phenylalanine residues were mutated to alanine (I-A/F-A) in both recombinant Mac1 proteins and recombinant CoVs, including murine hepatitis virus (MHV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The F-A mutant proteins had ADP-ribose binding and/or hydrolysis defects that led to attenuated replication and pathogenesis in cell culture and mice. In contrast, the I-A mutations had normal enzyme activity and enhanced ADP-ribose binding. Despite increased ADP-ribose binding, I-A mutant MERS-CoV and SARS-CoV-2 were highly attenuated in both cell culture and mice, indicating that this isoleucine residue acts as a gate that controls ADP-ribose binding for efficient virus replication. These results highlight the function of this highly conserved residue and provide unique insight into how macrodomains control ADP-ribose binding and hydrolysis to promote viral replication.

Indexed as

ADP-ribosylationADP-ribosylhydrolasecoronavirusinterferonmacrodomainMERS-CoVMHVnon-structural protein 3SARS-CoV-2

Identifiers

PMID38260573
PMCPMC10802294
OpenAlexW4390649728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.